ProShare Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,260
| Closed | -$139K | – | 1737 |
|
|
2018
Q3 | $139K | Sell |
2,260
-66
| -3% | -$4.06K | ﹤0.01% | 1647 |
|
|
2018
Q2 | $172K | Buy |
2,326
+441
| +23% | +$32.6K | ﹤0.01% | 1641 |
|
|
2018
Q1 | $124K | Sell |
1,885
-310
| -14% | -$20.4K | ﹤0.01% | 1621 |
|
|
2017
Q4 | $185K | Buy |
2,195
+137
| +7% | +$11.5K | ﹤0.01% | 1658 |
|
|
2017
Q3 | $238K | Buy |
2,058
+119
| +6% | +$13.8K | ﹤0.01% | 1224 |
|
|
2017
Q2 | $227K | Buy |
1,939
+251
| +15% | +$29.4K | ﹤0.01% | 1287 |
|
|
2017
Q1 | $208K | Sell |
1,688
-440
| -21% | -$54.2K | ﹤0.01% | 1437 |
|
|
2016
Q4 | $290K | Buy |
2,128
+216
| +11% | +$29.4K | ﹤0.01% | 1387 |
|
|
2016
Q3 | $381K | Sell |
1,912
-353
| -16% | -$70.3K | 0.01% | 1058 |
|
|
2016
Q2 | $294K | Buy |
2,265
+216
| +11% | +$28K | ﹤0.01% | 1223 |
|
|
2016
Q1 | $192K | Sell |
2,049
-203
| -9% | -$19K | ﹤0.01% | 1433 |
|
|
2015
Q4 | $456K | Buy |
+2,252
| New | +$456K | 0.01% | 1074 |
|